Procaps Group S.A. (NASDAQ:PROC – Get Free Report)’s share price was down 40.3% on Thursday . The company traded as low as $0.77 and last traded at $0.95. Approximately 658,169 shares changed hands during mid-day trading, an increase of 2,938% from the average daily volume of 21,666 shares. The stock had previously closed at $1.59.
Procaps Group Stock Down 40.3 %
The business’s fifty day simple moving average is $1.74 and its two-hundred day simple moving average is $1.79.
Institutional Trading of Procaps Group
A hedge fund recently bought a new stake in Procaps Group stock. Itau Unibanco Holding S.A. purchased a new stake in Procaps Group S.A. (NASDAQ:PROC – Free Report) in the fourth quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission. The institutional investor purchased 177,974 shares of the company’s stock, valued at approximately $416,000. Itau Unibanco Holding S.A. owned 0.16% of Procaps Group at the end of the most recent reporting period.
About Procaps Group
Procaps Group SA develops, produces, and markets pharmaceutical solutions worldwide. The company formulates, manufactures, and markets branded prescription drugs in various therapeutic areas, including feminine care products, pain relief, skin care, digestive health, growth and development, cardiology, vision care, central nervous system, and respiratory.
Further Reading
- Five stocks we like better than Procaps Group
- How to Invest in Biotech Stocks
- Unity Stock: Is a True Turnaround Finally Taking Shape?
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- DuPont’s Electronics Spinoff: The Start of Something Big
- Are Penny Stocks a Good Fit for Your Portfolio?
- The Trade Desk Crashes on Earnings, But Growth Catalysts Persist
Receive News & Ratings for Procaps Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procaps Group and related companies with MarketBeat.com's FREE daily email newsletter.
